Seema Hashmi
Sindh Institute of Urology and Transplantation
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Seema Hashmi.
Journal of Medical Genetics | 2007
Juliana Helou; Edgar A. Otto; Massimo Attanasio; Susan J. Allen; Melissa A. Parisi; Ian A. Glass; Boris Utsch; Seema Hashmi; Elisa Fazzi; Heymut Omran; John F. O'Toole; John A. Sayer; Friedhelm Hildebrandt
Background: Nephronophthisis (NPHP) is an autosomal recessive cystic kidney disease that constitutes the most common genetic cause of renal failure in the first three decades of life. Using positional cloning, six genes (NPHP1-6) have been identified as mutated in NPHP. In Joubert syndrome (JBTS), NPHP may be associated with cerebellar vermis aplasia/hypoplasia, retinal degeneration and mental retardation. In Senior–Løken syndrome (SLSN), NPHP is associated with retinal degeneration. Recently, mutations in NPHP6/CEP290 were identified as a new cause of JBTS. Methods: Mutational analysis was performed on a worldwide cohort of 75 families with SLSN, 99 families with JBTS and 21 families with isolated nephronophthisis. Results: Six novel and six known truncating mutations, one known missense mutation and one novel 3 bp pair in-frame deletion were identified in a total of seven families with JBTS, two families with SLSN and one family with isolated NPHP.
Gene | 2012
Aiysha Abid; Shagufta Khaliq; Saba Shahid; Ali Lanewala; Mohammad Mubarak; Seema Hashmi; Javed Iqbal Kazi; Tahir Masood; Farkhanda Hafeez; Syed Ali Anwar Naqvi; Syed Adeeb-ul-hasan Rizvi; Syed Qasim Mehdi
BACKGROUND Mutations in the NPHS1 and NPHS2 genes are among the main causes of early-onset and familial steroid resistant nephrotic syndrome respectively. This study was carried out to assess the frequencies of mutations in these two genes in a cohort of Pakistani pediatric NS patients. METHODS Mutation analysis was carried out by direct sequencing of the NPHS1 and NPHS2 genes in 145 nephrotic syndrome (NS) patients. This cohort included 36 samples of congenital or infantile onset NS cases and 39 samples of familial cases obtained from 30 families. RESULTS A total of 7 homozygous (6 novel) mutations were found in the NPHS1 gene and 4 homozygous mutations in the NPHS2 gene. All mutations in the NPHS1 gene were found in the early onset cases. Of these, one patient has a family history of NS. Homozygous p.R229Q mutation in the NPHS2 gene was found in two children with childhood-onset NS. CONCLUSIONS Our results show a low prevalence of disease causing mutations in the NPHS1 (22% early onset, 5.5% overall) and NPHS2 (3.3% early onset and 3.4% overall) genes in the Pakistani NS children as compared to the European populations. In contrast to the high frequency of the NPHS2 gene mutations reported for familial SRNS in Europe, no mutation was found in the familial Pakistani cases. To our knowledge, this is the first comprehensive screening of the NPHS1 and NPHS2 gene mutations in sporadic and familial NS cases from South Asia.
Journal of Clinical Investigation | 2017
Svjetlana Lovric; Sara Goncalves; Heon Yung Gee; Babak Oskouian; Honnappa Srinivas; Won Il Choi; Shirlee Shril; Shazia Ashraf; Weizhen Tan; Jia Rao; Merlin Airik; David Schapiro; Daniela A. Braun; Carolin E. Sadowski; Eugen Widmeier; Tilman Jobst-Schwan; Johanna Magdalena Schmidt; Vladimir Girik; Guido Capitani; Jung H. Suh; Noelle Lachaussée; Christelle Arrondel; Julie Patat; Olivier Gribouval; Monica Furlano; Olivia Boyer; Alain Schmitt; Vincent Vuiblet; Seema Hashmi; Rainer Wilcken
Steroid-resistant nephrotic syndrome (SRNS) causes 15% of chronic kidney disease cases. A mutation in 1 of over 40 monogenic genes can be detected in approximately 30% of individuals with SRNS whose symptoms manifest before 25 years of age. However, in many patients, the genetic etiology remains unknown. Here, we have performed whole exome sequencing to identify recessive causes of SRNS. In 7 families with SRNS and facultative ichthyosis, adrenal insufficiency, immunodeficiency, and neurological defects, we identified 9 different recessive mutations in SGPL1, which encodes sphingosine-1-phosphate (S1P) lyase. All mutations resulted in reduced or absent SGPL1 protein and/or enzyme activity. Overexpression of cDNA representing SGPL1 mutations resulted in subcellular mislocalization of SGPL1. Furthermore, expression of WT human SGPL1 rescued growth of SGPL1-deficient dpl1&Dgr; yeast strains, whereas expression of disease-associated variants did not. Immunofluorescence revealed SGPL1 expression in mouse podocytes and mesangial cells. Knockdown of Sgpl1 in rat mesangial cells inhibited cell migration, which was partially rescued by VPC23109, an S1P receptor antagonist. In Drosophila, Sply mutants, which lack SGPL1, displayed a phenotype reminiscent of nephrotic syndrome in nephrocytes. WT Sply, but not the disease-associated variants, rescued this phenotype. Together, these results indicate that SGPL1 mutations cause a syndromic form of SRNS.
Kidney International | 2016
Daniela A. Braun; Markus Schueler; Jan Halbritter; Heon Yung Gee; Jonathan D. Porath; Jennifer A. Lawson; Rannar Airik; Shirlee Shril; Susan J. Allen; Deborah Stein; Adila Al Kindy; Bodo B. Beck; Nurcan Cengiz; Khemchand N. Moorani; Fatih Ozaltin; Seema Hashmi; John A. Sayer; Detlef Bockenhauer; Neveen A. Soliman; Edgar A. Otto; Richard P. Lifton; Friedhelm Hildebrandt
Chronically increased echogenicity on renal ultrasound is a sensitive early finding of chronic kidney disease that can be detected before manifestation of other symptoms. Increased echogenicity, however, is not specific for a certain etiology of chronic kidney disease. Here, we performed whole exome sequencing in 79 consanguineous or familial cases of suspected nephronophthisis in order to determine the underlying molecular disease cause. In 50 cases, there was a causative mutation in a known monogenic disease gene. In 32 of these cases whole exome sequencing confirmed the diagnosis of a nephronophthisis-related ciliopathy. In 8 cases it revealed the diagnosis of a renal tubulopathy. The remaining 10 cases were identified as Alport syndrome (4), autosomal-recessive polycystic kidney disease (2), congenital anomalies of the kidney and urinary tract (3), and APECED syndrome (1). In 5 families, in whom mutations in known monogenic genes were excluded, we applied homozygosity mapping for variant filtering, and identified 5 novel candidate genes (RBM48, FAM186B, PIAS1, INCENP, and RCOR1) for renal ciliopathies. Thus, whole exome sequencing allows the detection of the causative mutation in 2/3 of affected individuals, thereby presenting the etiologic diagnosis and allows identification of novel candidate genes.
Apmis | 2011
Muhammed Mubarak; Javed Iqbal Kazi; Shaheera Shakeel; Ali Lanewala; Seema Hashmi; Fazal Akhter
Mubarak M, Kazi JI, Shakeel S, Lanewala A, Hashmi S, Akhter F. Clinicopathologic characteristics and steroid response of IgM nephropathy in children presenting with idiopathic nephrotic syndrome, APMIS 2011; 119: 180–186.
The Scientific World Journal | 2012
Muhammed Mubarak; Javed Iqbal Kazi; Shaheera Shakeel; Ali Lanewala; Seema Hashmi
Steroid-resistant nephrotic syndrome (SRNS) is a common problem in pediatric nephrology practice. There is currently little information in the literature on the spectrum of histopathologic lesions in children presenting with SRNS in Pakistan. This study was designed to determine the histopathologic lesions in children presenting with SRNS at our center. The study was conducted at the Histopathology Department, Sindh Institute of Urology and Transplantation (SIUT) from January 2009 to August 2011. All children (≤16 years) presenting with SRNS, in whom renal biopsies were performed, were included. Their demographic, clinical, laboratory, and histopathological data were retrieved from files and original renal biopsy forms. The results were analyzed by SPSS version 10.0. A total of 147 children were included. Of these, 91 (61.9%) were males and 56 (38.1%) females, with male-to-female ratio of 1.6 : 1. The mean age was 7.03 ± 4.0 years (range: 6 months–16 years). The histopathological lesions seen on renal biopsies comprised of focal segmental glomerulosclerosis (FSGS) (38.5%), followed by minimal change disease (MCD) (23.2%), IgM nephropathy (IgMN) (13.6%), idiopathic mesangial proliferative GN (10.2%), membranous GN (8.2%), and mesangiocapillary GN (4.8%). Our results indicate that FSGS is the predominant lesion in children with SRNS, followed by MCD and IgMN.
Pediatric Nephrology | 2008
Andreas Dietrich; Verena Matejas; Martin Bitzan; Seema Hashmi; Cathy Kiraly-Borri; Shuan-Pei Lin; Eva Mildenberger; Bernd Hoppe; Lars Palm; Takashi Shiihara; Jens-Oliver Steiss; Jeng-Daw Tsai; Udo Vester; Stefanie Weber; Elke Wühl; Kristina Zepf; Martin Zenker
Galloway–Mowat syndrome (GMS) is a rare autosomal recessive disorder characterized by early onset nephrotic syndrome and microcephaly with various anomalies of the central nervous system. GMS likely represents a heterogeneous group of disorders with hitherto unknown genetic etiology. The clinical phenotype to some extent overlaps that of Pierson syndrome (PS), which comprises congenital nephrotic syndrome and distinct ocular abnormalities but which may also include neurodevelopmental deficits and microcephaly. PS is caused by mutations of LAMB2, the gene encoding laminin β2. We hypothesized that GMS might be allelic to PS or be caused by defects in proteins that interact with laminin β2. In a cohort of 18 patients with GMS or a GMS-like phenotype we therefore analyzed the genes encoding laminin β2 (LAMB2), laminin α5 (LAMA5), α3-integrin (ITGA3), β1-integrin (ITGB1) and α-actinin-4 (ACTN4), but we failed to find causative mutations in these genes. We inferred that LAMA5, ITGA3, ITGB1, and ACTN4 are not directly involved in the pathogenesis of GMS. We excluded LAMB2 as a candidate gene for GMS. Further studies are required, including linkage analysis in families with GMS to identify genes underlying this disease.
American Journal of Transplantation | 2013
Syed Adibul Hasan Rizvi; S. Sultan; Mirza Naqi Zafar; S.A.A Naqvi; Ali Lanewala; Seema Hashmi; Tahir Aziz; A. S. Hassan; B. Ali; Rehan Mohsin; Muhammed Mubarak; S. Farasat; S. F. Akhtar; Altaf Hashmi; Manzoor Hussain; Z. Hussain
The prevalence of pediatric RRT and transplantation are low in developing countries, 6–12 and <1 to 5 per million child population (pmcp), respectively. This is due to low GDP/capita of <
Kidney International | 2018
Ankana Daga; Amar J. Majmundar; Daniela A. Braun; Heon Yung Gee; Jennifer A. Lawson; Shirlee Shril; Tilman Jobst-Schwan; Asaf Vivante; David Schapiro; Weizhen Tan; Jillian K. Warejko; Eugen Widmeier; Caleb P. Nelson; Hanan M. Fathy; Zoran Gucev; Neveen A. Soliman; Seema Hashmi; Jan Halbritter; Margarita Halty; Jameela A. Kari; Sherif El-Desoky; Michael A. J. Ferguson; Michael J. Somers; Avram Z. Traum; Deborah Stein; Ghaleb Daouk; Nancy Rodig; Avi Katz; Christian Hanna; Andrew L. Schwaderer
10 000, government expenditure on health of <2.6–9% of GDP and paucity of facilities. The reported incidence of pediatric CKD and ESRD is <1.0–8 and 3.4–35 pmcp, respectively. RRT and transplantation are offered mostly in private centers in cities where HD costs
Clinical Journal of The American Society of Nephrology | 2018
Jillian K. Warejko; Weizhen Tan; Ankana Daga; David Schapiro; Jennifer A. Lawson; Shirlee Shril; Svjetlana Lovric; Shazia Ashraf; Jia Rao; Tobias Hermle; Tilman Jobst-Schwan; Eugen Widmeier; Amar J. Majmundar; Ronen Schneider; Heon Yung Gee; J. Magdalena Schmidt; Asaf Vivante; Amelie T. van der Ven; Hadas Ityel; Jing Chen; Carolin E. Sadowski; Stefan Kohl; Werner L. Pabst; Makiko Nakayama; Michael J. Somers; Nancy Rodig; Ghaleb Daouk; Michelle A. Baum; Deborah Stein; Michael A. J. Ferguson
20–100/session and transplants